Guillain–Barré syndrome following COVID‐19 vaccine: A case report

Mohammad Sadegh Fakhari; Leila Poorsaadat; Behnam Mahmoodiyeh

doi:10.1002/ccr3.6451

Clinical Case Reports (Oct 2022)

Guillain–Barré syndrome following COVID‐19 vaccine: A case report

Mohammad Sadegh Fakhari,
Leila Poorsaadat,
Behnam Mahmoodiyeh

Affiliations

Mohammad Sadegh Fakhari: Student Research Committee Arak University of Medical Sciences Arak Iran
Leila Poorsaadat: Department of Neurology, School of Medicine Arak University of Medical Sciences Arak Iran
Behnam Mahmoodiyeh: Department of Anesthesiology, School of Medicine Arak University of Medical Sciences Arak Iran

DOI: https://doi.org/10.1002/ccr3.6451
Journal volume & issue: Vol. 10, no. 10
pp. n/a – n/a

Abstract

Read online

Abstract Coronavirus disease is a viral infection affecting different organs with various morbidities and mortality. Vaccines are used to control the disease. COVID‐19 vaccines have brought many benefits but their adverse effects should not be ignored. Here, we report a case of Guillain–Barré Syndrome Following Sinopharm COVID‐19 Vaccine.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2050-0904

About the journal

Abstract

Keywords